Navigation Links
Intercept Pharmaceuticals and Servier Announce Agreement for Intercept's TGR5 Research Program in Type 2 Diabetes
Date:8/9/2011

NEW YORK, and NEUILLY, France, Aug. 9, 2011 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (Intercept) and Les Laboratoires Servier (Servier) today announced that they have entered into a worldwide ex-U.S. and Japan agreement for the discovery and development of novel TGR5 agonists for the treatment of type 2 diabetes and other metabolic indications. The collaboration will leverage Intercept's drug discovery platform based on its proprietary bile acid analog chemistry and expertise targeting TGR5 and other bile receptors.

Under the terms of the agreement, Intercept will receive up to $163 million in total upfront, research support and milestone payments, as well as royalties on sales, based on the successful outcome of the collaboration. Intercept and Servier will jointly support the discovery effort, while Servier alone will be responsible for all costs associated with the global development, regulatory approval and commercialization of any compound selected as a lead candidate by the parties. Intercept retains all rights in the U.S. and Japan.

"This agreement provides important validation of our approach to targeting TGR5," said Mark Pruzanski, MD, Intercept's President and Chief Executive Officer. "Type 2 diabetes and associated metabolic disorders have reached epidemic proportions globally and there is a critical need for novel effective and safe drugs. Intercept is uniquely positioned to exploit the therapeutic potential of rationally modified bile acids, which play a central role in the maintenance of metabolic homeostasis.  I am thrilled to enter this agreement with Servier given the company's commitment to research and expertise in this therapeutic area."

"We are very happy to enter into this collaboration with Intercept which will allow us to further expand our diabetes and metabolic disease franchise," stated Emmanuel Canet, MD, PhD, Head of Servier R&D. "TGR5 is a target of great interest with its effects on GLP-1 that c
'/>"/>

SOURCE Intercept Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intercept Pharmaceuticals Announces Positive Phase II Results for Obeticholic Acid (INT-747) as Monotherapy in Primary Biliary Cirrhosis
2. Dainippon Sumitomo Pharma and Intercept Pharmaceuticals Announce Agreement to Develop and Commercialize Obeticholic Acid (INT-747) for Chronic Liver Disease
3. Initiation of FLINT Announced by NIDDK: Study of Intercept Pharmaceuticals Obeticholic Acid (INT-747) in NASH
4. Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic Steatohepatitis (NASH)
5. Intercept Pharmaceuticals Raises $25 Million Series B Financing
6. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
7. Intercept Pharmaceuticals FXR Agonist INT-747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease
8. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Second Quarter Results
9. K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business
10. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
11. Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... WALTHAM, Mass. , May 26, 2015 /PRNewswire/ ... the 62 nd Annual Meeting of the ... methods of monitoring patient respiration in hospitals miss ... serious risks to patients. The findings conclude that ... by Respiratory Motion, Inc. more consistently protects patients ...
(Date:5/26/2015)... , May 26, 2015 Boehringer Ingelheim ... Administration (FDA) approved once-daily STIOLTO™ RESPIMAT ® ... been approved as a long-term, once-daily maintenance treatment ... pulmonary disease (COPD), including chronic bronchitis and/or emphysema. ... or acute deterioration of COPD. COPD, ...
(Date:5/26/2015)... , May 26, 2015  Organovo Holdings, Inc. ... on delivering breakthrough 3D bioprinting technology, announced today that ... the Jeffries 2015 Healthcare Conference, to be held in ... 4, 2015.  Keith Murphy , Chairman and Chief ... recent key advances and partnerships. Details of ...
Breaking Medicine Technology:Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 2Organovo Holdings, Inc. To Present at Jeffries 2015 Healthcare Conference 3
... may still seem radically innovative in the context of ... had been the norm for many years. In automobile ... vehicles with only occasional human oversight. The result has ... positive returns in profit and productivity. These days, only ...
... necessary to plan or evaluate anticoagulant therapy, ... hyperhomocystinemia, elevated factor VIII levels, dysfibrinogenemia, factor ... and to assess acquired conditions, such as ... others. Prothrombin levels are also monitored along ...
Cached Medicine Technology:Lab Automation Networks Proliferating 2Lab Automation Networks Proliferating 3Lab Automation Networks Proliferating 4Prothrombin Time Comes in Small (CLIA-Waived) Packages 2Prothrombin Time Comes in Small (CLIA-Waived) Packages 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 Based on ... AnyTranscription has undertaken a comprehensive upgrade of its purchasing ... user experience. To thank users for their feedback and ... five minute trial transcription service promotion. , ... May 26 to June 9 this year. During this ...
(Date:5/26/2015)... Adenna, Inc ., worldwide supplier of ... announce the launch of Enov8 (pronounced “innovate”), ... polyethylene (PE) and approved by the U.S. FDA for ... , The Enov8 glove might look like the PE ... but our proprietary formula and production technology brings to ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
(Date:5/26/2015)... Many sexy cocktail dresses inspired by celebrities ... recently. Now, TheCelebrityDresses.com is offering great discounts on ... off. The company aims to help ladies from ... dollars on valuable, trendy formal outfits. , TheCelebrityDresses.com ... special occasion dresses. Their dresses are popular among ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 U.S. Food ... in the United States are extensive and can be ... firm that helps medical device companies comply with FDA ... medical device companies navigate FDA requirements. , 1. ... the United States can be a lengthy process depending ...
Breaking Medicine News(10 mins):Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4
... Studies show combo chemotherapy, new drug prolonged lives of ... News) -- Researchers report they prolonged survival for some ... the median survival is currently only about six months. ... called crizotinib shrank tumors in the majority of lung ...
... - Dasatanib, a medication currently approved as treatment for ... better responses as a first therapy than the existing ... Texas MD Anderson Cancer Center. The findings were ... Society of Clinical Oncology today, and published in the ...
... In a ... ahm are paying tribute to local people helping and inspiring others. , ... (PRWEB) June 5, 2010 -- i98FM and ahm ... ahm Local Hero Awards., , , , ,In a joint effort to recognise Illawarra residents ...
... ... 600 persons in drug rehabs and prisons , ... (PRWEB) June 5, 2010 -- President Narconon International, Clark ... unique Narconon® drug-free withdrawal and relapse prevention technology to Mexico. Accompanied by U.S. and ...
... ... promising to make online buying a simple, easy one-stop shopping experience. , ... (PRWEB) June 5, 2010 -- With online shopping ... many choices, shipping arrangements and payment procedures that it is easy to get confused, which ...
... to new research that will be presented on Saturday, June ... of Dental Sleep Medicine, nasendoscopy may help dentists predict oral ... flexible endoscope being inserted through the nasal cavity. The tip ... velopharynx and oro-/hypopharynx. OAT has been shown to be ...
Cached Medicine News:Health News:Researchers Report Treatment Headway Against Lung Cancer 2Health News:Researchers Report Treatment Headway Against Lung Cancer 3Health News:Second-line CML drug evokes faster response, fewer side effects, pivotal study finds 2Health News:i98 Fm And ahm Announce Local Hero Finalists 2Health News:i98 Fm And ahm Announce Local Hero Finalists 3Health News:Narconon Campaigns to Help Mexico Reduce Drug-related Violence in Sonora and Michoacan 2Health News:BestMassage.com Launches Its Brand New Customer-Focused Website 2Health News:Nasendoscopy proves useful in predicting treatment success in sleep apnea patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: